Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Virosomal Vaccine PEV3A and FP9-MVA ME-TRAP. A Phase I / IIa Controlled Challenge Trial

NCT00408668 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00408668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Virosomal Vaccine PEV3A and FP9-MVA ME-TRAP. A Phase I / IIa Controlled Challenge Trial
Lead sponsor
University of Oxford
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2005
Completion date
February 28, 2006
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria, falciparum